Selected research
Market Analysis & Forecast
Global Fast-disintegrating Tablets Market Analysis and Forecast 2026-2032
Market perspective
The global Fast-disintegrating Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Fast-disintegrating Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Fast-disintegrating Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Fast-disintegrating Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Fast-disintegrating Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Fast-disintegrating Tablets include Teva, Johnson and Johnson, Merck, Mylan, Eli Lilly and Company, Pfizer, GSK, AstraZeneca and Otsuka, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Fast-disintegrating Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Fast-disintegrating Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Fast-disintegrating Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fast-disintegrating Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Fast-disintegrating Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Fast-disintegrating Tablets sales, projected growth trends, production technology, application and end-user industry.
Fast-disintegrating Tablets Segment by Company
Teva
Johnson and Johnson
Merck
Mylan
Eli Lilly and Company
Pfizer
GSK
AstraZeneca
Otsuka
Conquer
Bristol-Myers Squibb
Fast-disintegrating Tablets Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Fast-disintegrating Tablets Segment by Application
CVS Diseases
Gastrointestinal Diseases
CNS Diseases
Other
Fast-disintegrating Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fast-disintegrating Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fast-disintegrating Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fast-disintegrating Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Fast-disintegrating Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Fast-disintegrating Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fast-disintegrating Tablets sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anti-Psychotics Drug
- Anti-Epileptics Drug
- Other
Applications
- CVS Diseases
- Gastrointestinal Diseases
- CNS Diseases
- Other
Companies covered
- Teva
- Johnson and Johnson
- Merck
- Mylan
- Eli Lilly and Company
- Pfizer
- GSK
- AstraZeneca
- Otsuka
- Conquer
- Bristol-Myers Squibb
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Fast-disintegrating Tablets Market by Type
- 1.2.1 Global Fast-disintegrating Tablets Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Anti-Psychotics Drug
- 1.2.3 Anti-Epileptics Drug
- 1.2.4 Other
- 1.3 Fast-disintegrating Tablets Market by Application
- 1.3.1 Global Fast-disintegrating Tablets Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 CVS Diseases
- 1.3.3 Gastrointestinal Diseases
- 1.3.4 CNS Diseases
- 1.3.5 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Fast-disintegrating Tablets Market Dynamics
- 2.1 Fast-disintegrating Tablets Industry Trends
- 2.2 Fast-disintegrating Tablets Industry Drivers
- 2.3 Fast-disintegrating Tablets Industry Opportunities and Challenges
- 2.4 Fast-disintegrating Tablets Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Fast-disintegrating Tablets Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Fast-disintegrating Tablets Revenue by Region
- 3.2.1 Global Fast-disintegrating Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Fast-disintegrating Tablets Revenue by Region (2021-2026)
- 3.2.3 Global Fast-disintegrating Tablets Revenue by Region (2027-2032)
- 3.2.4 Global Fast-disintegrating Tablets Revenue Market Share by Region (2021-2032)
- 3.3 Global Fast-disintegrating Tablets Sales Estimates and Forecasts 2021-2032
- 3.4 Global Fast-disintegrating Tablets Sales by Region
- 3.4.1 Global Fast-disintegrating Tablets Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Fast-disintegrating Tablets Sales by Region (2021-2026)
- 3.4.3 Global Fast-disintegrating Tablets Sales by Region (2027-2032)
- 3.4.4 Global Fast-disintegrating Tablets Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Fast-disintegrating Tablets Revenue by Manufacturers
- 4.1.1 Global Fast-disintegrating Tablets Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Fast-disintegrating Tablets Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Fast-disintegrating Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Fast-disintegrating Tablets Sales by Manufacturers
- 4.2.1 Global Fast-disintegrating Tablets Sales by Manufacturers (2021-2026)
- 4.2.2 Global Fast-disintegrating Tablets Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Fast-disintegrating Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Fast-disintegrating Tablets Sales Price by Manufacturers (2021-2026)
- 4.4 Global Fast-disintegrating Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Fast-disintegrating Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Fast-disintegrating Tablets Manufacturers, Product Type & Application
- 4.7 Global Fast-disintegrating Tablets Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Fast-disintegrating Tablets Market CR5 and HHI
- 4.8.2 2025 Fast-disintegrating Tablets Tier 1, Tier 2, and Tier 3
5 Fast-disintegrating Tablets Market by Type
- 5.1 Global Fast-disintegrating Tablets Revenue by Type
- 5.1.1 Global Fast-disintegrating Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Fast-disintegrating Tablets Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Fast-disintegrating Tablets Revenue Market Share by Type (2021-2032)
- 5.2 Global Fast-disintegrating Tablets Sales by Type
- 5.2.1 Global Fast-disintegrating Tablets Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Fast-disintegrating Tablets Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Fast-disintegrating Tablets Sales Market Share by Type (2021-2032)
- 5.3 Global Fast-disintegrating Tablets Price by Type
6 Fast-disintegrating Tablets Market by Application
- 6.1 Global Fast-disintegrating Tablets Revenue by Application
- 6.1.1 Global Fast-disintegrating Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Fast-disintegrating Tablets Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Fast-disintegrating Tablets Revenue Market Share by Application (2021-2032)
- 6.2 Global Fast-disintegrating Tablets Sales by Application
- 6.2.1 Global Fast-disintegrating Tablets Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Fast-disintegrating Tablets Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Fast-disintegrating Tablets Sales Market Share by Application (2021-2032)
- 6.3 Global Fast-disintegrating Tablets Price by Application
7 Company Profiles
- 7.1 Teva
- 7.1.1 Teva Company Information
- 7.1.2 Teva Business Overview
- 7.1.3 Teva Fast-disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Teva Fast-disintegrating Tablets Product Portfolio
- 7.1.5 Teva Recent Developments
- 7.2 Johnson and Johnson
- 7.2.1 Johnson and Johnson Company Information
- 7.2.2 Johnson and Johnson Business Overview
- 7.2.3 Johnson and Johnson Fast-disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Johnson and Johnson Fast-disintegrating Tablets Product Portfolio
- 7.2.5 Johnson and Johnson Recent Developments
- 7.3 Merck
- 7.3.1 Merck Company Information
- 7.3.2 Merck Business Overview
- 7.3.3 Merck Fast-disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Merck Fast-disintegrating Tablets Product Portfolio
- 7.3.5 Merck Recent Developments
- 7.4 Mylan
- 7.4.1 Mylan Company Information
- 7.4.2 Mylan Business Overview
- 7.4.3 Mylan Fast-disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Mylan Fast-disintegrating Tablets Product Portfolio
- 7.4.5 Mylan Recent Developments
- 7.5 Eli Lilly and Company
- 7.5.1 Eli Lilly and Company Company Information
- 7.5.2 Eli Lilly and Company Business Overview
- 7.5.3 Eli Lilly and Company Fast-disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Eli Lilly and Company Fast-disintegrating Tablets Product Portfolio
- 7.5.5 Eli Lilly and Company Recent Developments
- 7.6 Pfizer
- 7.6.1 Pfizer Company Information
- 7.6.2 Pfizer Business Overview
- 7.6.3 Pfizer Fast-disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Pfizer Fast-disintegrating Tablets Product Portfolio
- 7.6.5 Pfizer Recent Developments
- 7.7 GSK
- 7.7.1 GSK Company Information
- 7.7.2 GSK Business Overview
- 7.7.3 GSK Fast-disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 GSK Fast-disintegrating Tablets Product Portfolio
- 7.7.5 GSK Recent Developments
- 7.8 AstraZeneca
- 7.8.1 AstraZeneca Company Information
- 7.8.2 AstraZeneca Business Overview
- 7.8.3 AstraZeneca Fast-disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 AstraZeneca Fast-disintegrating Tablets Product Portfolio
- 7.8.5 AstraZeneca Recent Developments
- 7.9 Otsuka
- 7.9.1 Otsuka Company Information
- 7.9.2 Otsuka Business Overview
- 7.9.3 Otsuka Fast-disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Otsuka Fast-disintegrating Tablets Product Portfolio
- 7.9.5 Otsuka Recent Developments
- 7.10 Conquer
- 7.10.1 Conquer Company Information
- 7.10.2 Conquer Business Overview
- 7.10.3 Conquer Fast-disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Conquer Fast-disintegrating Tablets Product Portfolio
- 7.10.5 Conquer Recent Developments
- 7.11 Bristol-Myers Squibb
- 7.11.1 Bristol-Myers Squibb Company Information
- 7.11.2 Bristol-Myers Squibb Business Overview
- 7.11.3 Bristol-Myers Squibb Fast-disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Bristol-Myers Squibb Fast-disintegrating Tablets Product Portfolio
- 7.11.5 Bristol-Myers Squibb Recent Developments
8 North America
- 8.1 North America Fast-disintegrating Tablets Market Size by Type
- 8.1.1 North America Fast-disintegrating Tablets Revenue by Type (2021-2032)
- 8.1.2 North America Fast-disintegrating Tablets Sales by Type (2021-2032)
- 8.1.3 North America Fast-disintegrating Tablets Price by Type (2021-2032)
- 8.2 North America Fast-disintegrating Tablets Market Size by Application
- 8.2.1 North America Fast-disintegrating Tablets Revenue by Application (2021-2032)
- 8.2.2 North America Fast-disintegrating Tablets Sales by Application (2021-2032)
- 8.2.3 North America Fast-disintegrating Tablets Price by Application (2021-2032)
- 8.3 North America Fast-disintegrating Tablets Market Size by Country
- 8.3.1 North America Fast-disintegrating Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Fast-disintegrating Tablets Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Fast-disintegrating Tablets Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Fast-disintegrating Tablets Market Size by Type
- 9.1.1 Europe Fast-disintegrating Tablets Revenue by Type (2021-2032)
- 9.1.2 Europe Fast-disintegrating Tablets Sales by Type (2021-2032)
- 9.1.3 Europe Fast-disintegrating Tablets Price by Type (2021-2032)
- 9.2 Europe Fast-disintegrating Tablets Market Size by Application
- 9.2.1 Europe Fast-disintegrating Tablets Revenue by Application (2021-2032)
- 9.2.2 Europe Fast-disintegrating Tablets Sales by Application (2021-2032)
- 9.2.3 Europe Fast-disintegrating Tablets Price by Application (2021-2032)
- 9.3 Europe Fast-disintegrating Tablets Market Size by Country
- 9.3.1 Europe Fast-disintegrating Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Fast-disintegrating Tablets Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Fast-disintegrating Tablets Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Fast-disintegrating Tablets Market Size by Type
- 10.1.1 China Fast-disintegrating Tablets Revenue by Type (2021-2032)
- 10.1.2 China Fast-disintegrating Tablets Sales by Type (2021-2032)
- 10.1.3 China Fast-disintegrating Tablets Price by Type (2021-2032)
- 10.2 China Fast-disintegrating Tablets Market Size by Application
- 10.2.1 China Fast-disintegrating Tablets Revenue by Application (2021-2032)
- 10.2.2 China Fast-disintegrating Tablets Sales by Application (2021-2032)
- 10.2.3 China Fast-disintegrating Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Fast-disintegrating Tablets Market Size by Type
- 11.1.1 Asia Fast-disintegrating Tablets Revenue by Type (2021-2032)
- 11.1.2 Asia Fast-disintegrating Tablets Sales by Type (2021-2032)
- 11.1.3 Asia Fast-disintegrating Tablets Price by Type (2021-2032)
- 11.2 Asia Fast-disintegrating Tablets Market Size by Application
- 11.2.1 Asia Fast-disintegrating Tablets Revenue by Application (2021-2032)
- 11.2.2 Asia Fast-disintegrating Tablets Sales by Application (2021-2032)
- 11.2.3 Asia Fast-disintegrating Tablets Price by Application (2021-2032)
- 11.3 Asia Fast-disintegrating Tablets Market Size by Country
- 11.3.1 Asia Fast-disintegrating Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Fast-disintegrating Tablets Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Fast-disintegrating Tablets Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Fast-disintegrating Tablets Market Size by Type
- 12.1.1 SAMEA Fast-disintegrating Tablets Revenue by Type (2021-2032)
- 12.1.2 SAMEA Fast-disintegrating Tablets Sales by Type (2021-2032)
- 12.1.3 SAMEA Fast-disintegrating Tablets Price by Type (2021-2032)
- 12.2 SAMEA Fast-disintegrating Tablets Market Size by Application
- 12.2.1 SAMEA Fast-disintegrating Tablets Revenue by Application (2021-2032)
- 12.2.2 SAMEA Fast-disintegrating Tablets Sales by Application (2021-2032)
- 12.2.3 SAMEA Fast-disintegrating Tablets Price by Application (2021-2032)
- 12.3 SAMEA Fast-disintegrating Tablets Market Size by Country
- 12.3.1 SAMEA Fast-disintegrating Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Fast-disintegrating Tablets Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Fast-disintegrating Tablets Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Fast-disintegrating Tablets Value Chain Analysis
- 13.1.1 Fast-disintegrating Tablets Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Fast-disintegrating Tablets Production Mode & Process
- 13.2 Fast-disintegrating Tablets Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Fast-disintegrating Tablets Distributors
- 13.2.3 Fast-disintegrating Tablets Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst